Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under...
Upexi fell sharply during regular trading, last at $0.8582 as of ET 13:35, down 4.12% from the previous close of $0.8951, primarily driven by the company's disclosure of failure to satisfy a Nasdaq continued listing rule, along with ongoing market concerns over its capital maneuvers and cryptocurrency holdings. The stock hit an intraday low of $0.8500 and a high of only $0.9599, with the session's range narrowing significantly from the pre-market high of $1.010, forming a pattern of rally-fade. Q3 FY2026 revenue was $4.557 million, up 44.2% YoY, but net loss widened to $109.3 million, a 27.5x YoY increase, with an EPS of -$1.67 and a net profit margin of -2399.4%, reflecting deepening financial distress. The stock is now 91.92% below its 52-week high of $10.62, trades below both the MA20 ($0.89) and MA60 ($1.164), and is down 55.07% year-to-date. However, the company recently engaged Hivemind Capital in a three-year advisory agreement and completed a $19.5 million private placement to retire notes, steps that may help stabilize operations.
Survival Tactics and Strategic Pivots: Inside This Week's Outlier Tech and Utility Moves
Upexi (NASDAQ:UPXI) Trading Down 9.4% - Here's What Happened
The Fringe Economy: How Capital is Torn Between Safe Havens and Extreme Yields
Wall Street's Misfit Toys: Crypto Pivots, Inverse ETFs, and the Illusion of Strategy
Upexi gets Nasdaq notice for failing $1 minimum bid price rule
Upexi (NASDAQ:UPXI) Shares Up 0.1% - Time to Buy?